Cargando…
Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital Database
SIMPLE SUMMARY: The benefits of standard treatments in metastatic pancreatic cancer (mPC) in terms of overall survival (OS) remain to date unclear, especially after 70 years. Alongside geriatric and oncologic parameters, we showed that the gemcitabine + nab-paclitaxel regimen and anti-diabetic thera...
Autores principales: | Conti, Catherine, Pamoukdjian, Frédéric, Aparicio, Thomas, Mebarki, Soraya, Poisson, Johanne, Manceau, Gilles, Taieb, Julien, Rance, Bastien, Katsahian, Sandrine, Charles-Nelson, Anaïs, Paillaud, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909682/ https://www.ncbi.nlm.nih.gov/pubmed/35267412 http://dx.doi.org/10.3390/cancers14051105 |
Ejemplares similares
-
Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer
por: Burgassi, Fiamma, et al.
Publicado: (2021) -
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
por: Couderc, Anne-Laure, et al.
Publicado: (2023) -
Complications and Discharge after Radical Cystectomy for Older Patients with Muscle-Invasive Bladder Cancer: The ELCAPA-27 Cohort Study
por: Geiss, Romain, et al.
Publicado: (2021) -
Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers
por: Bayle, Arnaud, et al.
Publicado: (2021) -
Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE
por: Angeli, Eurydice, et al.
Publicado: (2020)